Guidance for industry : revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products.

Bibliographic Details
Corporate Author: Center for Biologics Evaluation and Research (U.S.)
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2002]
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS112744

Internet

https://purl.fdlp.gov/GPO/LPS112744

Available Online

Holdings details from Available Online
Call Number: HE 20.4802:P 92
 
Call Number Status Get It
HE 20.4802:P 92 Available